Eli Lilly forms 5 year Indian partnership

Eli Lilly has signed a five-year collaboration contract with the India firm Jubilant Organosys.

The agreement, put into place with the Jubilant subsidiaries Jubilant Biosys and Jubilant Chemsys, will focus on the development of new drugs in a range of areas.

Jubilant Biosys and Jubilant Chemsys will work on initial stages of drug discovery, sharing its developments, and analysis to bring drugs to fruition.

The financial details of the contract have not been disclosed but Eli Lilly will pay Jubilant on the meeting of certain development milestones.

Jubilant, which has chemical as well as pharmaceutical divisions, employs around 2,500 people in India and abroad and had a revenue in 2005 of around $270 million.

© Adfero Ltd